• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

嗅觉识别评分作为阿尔茨海默病淀粉样蛋白形成早期识别的替代方法。

Odor identification score as an alternative method for early identification of amyloidogenesis in Alzheimer's disease.

机构信息

Department of Dementia, Dementia Center, Federation of National Public Service Personnel Mutual Aid Associations, Toranomon Hospital, 2-2-2 Toranomon, Minato-ku, Tokyo, 105-8470, Japan.

Division of Dementia Research, Okinaka Memorial Institute for Medical Research, 2-2-2 Toranomon, Minato-ku, Tokyo, 105-8470, Japan.

出版信息

Sci Rep. 2024 Feb 26;14(1):4658. doi: 10.1038/s41598-024-54322-3.

DOI:10.1038/s41598-024-54322-3
PMID:38409432
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10897211/
Abstract

A simple screening test to identify the early stages of Alzheimer's disease (AD) is urgently needed. We investigated whether odor identification impairment can be used to differentiate between stages of the A/T/N classification (amyloid,  tau, neurodegeneration) in individuals with amnestic mild cognitive impairment or AD and in healthy controls. We collected data from 132 Japanese participants visiting the Toranomon Hospital dementia outpatient clinic. The odor identification scores correlated significantly with major neuropsychological scores, regardless of apolipoprotein E4 status, and with effective cerebrospinal fluid (CSF) biomarkers [amyloid β 42 (Aβ42) and the Aβ42/40 and phosphorylated Tau (p-Tau)/Aβ42 ratios] but not with ineffective biomarkers [Aβ40 and the p-Tau/total Tau ratio]. A weak positive correlation was observed between the corrected odor identification score (adjusted for age, sex, ApoE4 and MMSE), CSF Aβ42, and the Aβ42/40 ratio. The odor identification score demonstrated excellent discriminative power for the amyloidogenesis stage , according to the A/T/N classification, but was unsuitable for differentiating between the p-Tau accumulation and the neurodegeneration stages. After twelve odor species were analyzed, a version of the score comprising only four odors-India ink, wood, curry, and sweaty socks-proved highly effective in identifying AD amyloidogenesis, showing promise for the screening of preclinical AD.

摘要

我们迫切需要一种简单的筛查测试来识别阿尔茨海默病(AD)的早期阶段。我们研究了气味识别障碍是否可用于区分具有遗忘型轻度认知障碍或 AD 的个体以及健康对照者的 A/T/N 分类(淀粉样蛋白、tau、神经退行性变)的各个阶段。我们从访问 Toranomon 医院痴呆门诊的 132 名日本参与者中收集了数据。无论载脂蛋白 E4 状态如何,气味识别评分与主要神经心理学评分显著相关,与有效的脑脊液(CSF)生物标志物[淀粉样蛋白 β 42(Aβ42)和 Aβ42/40 以及磷酸化 Tau(p-Tau)/Aβ42 比值]相关,但与无效生物标志物[Aβ40 和 p-Tau/总 Tau 比值]无关。校正后的气味识别评分(校正年龄、性别、ApoE4 和 MMSE)、CSF Aβ42 和 Aβ42/40 比值之间观察到微弱的正相关。气味识别评分根据 A/T/N 分类对淀粉样蛋白形成阶段具有出色的区分能力,但不适合区分 p-Tau 积累和神经退行性变阶段。在分析了 12 种气味后,仅包含四种气味-墨水、木材、咖喱和臭袜子的评分版本在识别 AD 淀粉样蛋白形成方面非常有效,有望用于筛查临床前 AD。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fa8/10897211/0686b3528ba2/41598_2024_54322_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fa8/10897211/0686b3528ba2/41598_2024_54322_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fa8/10897211/0686b3528ba2/41598_2024_54322_Fig1_HTML.jpg

相似文献

1
Odor identification score as an alternative method for early identification of amyloidogenesis in Alzheimer's disease.嗅觉识别评分作为阿尔茨海默病淀粉样蛋白形成早期识别的替代方法。
Sci Rep. 2024 Feb 26;14(1):4658. doi: 10.1038/s41598-024-54322-3.
2
Relation of Odor Identification with Alzheimer's Disease Markers in Cerebrospinal Fluid and Cognition.气味识别与脑脊液中阿尔茨海默病标志物及认知的关系。
J Alzheimers Dis. 2017;60(3):1025-1034. doi: 10.3233/JAD-170564.
3
Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease.载脂蛋白 E 基因型与阿尔茨海默病脑脊液生物标志物的诊断准确性。
JAMA Psychiatry. 2014 Oct;71(10):1183-91. doi: 10.1001/jamapsychiatry.2014.1060.
4
Longitudinal structural cerebral changes related to core CSF biomarkers in preclinical Alzheimer's disease: A study of two independent datasets.与临床前阿尔茨海默病核心 CSF 生物标志物相关的纵向结构脑变化:两项独立数据集研究。
Neuroimage Clin. 2018 Apr 16;19:190-201. doi: 10.1016/j.nicl.2018.04.016. eCollection 2018.
5
Reciprocal Predictive Relationships between Amyloid and Tau Biomarkers in Alzheimer's Disease Progression: An Empirical Model.阿尔茨海默病进展中淀粉样蛋白和 tau 生物标志物的相互预测关系:一个经验模型。
J Neurosci. 2019 Sep 11;39(37):7428-7437. doi: 10.1523/JNEUROSCI.1056-19.2019. Epub 2019 Jul 26.
6
Cerebrospinal fluid biomarkers distinguish postmortem-confirmed Alzheimer's disease from other dementias and healthy controls in the OPTIMA cohort.在OPTIMA队列中,脑脊液生物标志物可将经尸检确诊的阿尔茨海默病与其他痴呆症及健康对照区分开来。
J Alzheimers Dis. 2015;44(2):525-39. doi: 10.3233/JAD-141725.
7
Additional use of Aβ₄₂/Aβ₄₀ ratio with cerebrospinal fluid biomarkers P-tau and Aβ₄₂ increases the level of evidence of Alzheimer's disease pathophysiological process in routine practice.在常规实践中,将β淀粉样蛋白42(Aβ₄₂)/β淀粉样蛋白40(Aβ₄₀)比值与脑脊液生物标志物磷酸化tau蛋白(P-tau)和Aβ₄₂一起使用,可提高阿尔茨海默病病理生理过程的证据水平。
J Alzheimers Dis. 2014;41(2):377-86. doi: 10.3233/JAD-131838.
8
Progression to dementia in memory clinic patients with mild cognitive impairment and normal β-amyloid.记忆门诊中伴有正常β-淀粉样蛋白的轻度认知障碍患者向痴呆的进展。
Alzheimers Res Ther. 2019 Dec 5;11(1):99. doi: 10.1186/s13195-019-0557-1.
9
Association between CSF Aβ42 and amyloid negativity in patients with different stage mild cognitive impairment.不同阶段轻度认知障碍患者脑脊液 Aβ42 与淀粉样阴性的相关性。
Neurosci Lett. 2021 May 29;754:135765. doi: 10.1016/j.neulet.2021.135765. Epub 2021 Mar 2.
10
Plasma apolipoprotein E levels in longitudinally followed patients with mild cognitive impairment and Alzheimer's disease.在纵向随访的轻度认知障碍和阿尔茨海默病患者中,血浆载脂蛋白 E 水平。
Alzheimers Res Ther. 2022 Aug 24;14(1):115. doi: 10.1186/s13195-022-01058-9.

引用本文的文献

1
Early Locus Coeruleus noradrenergic axon loss drives olfactory dysfunction in Alzheimer's disease.早期蓝斑去甲肾上腺素能轴突丧失导致阿尔茨海默病嗅觉功能障碍。
Nat Commun. 2025 Aug 8;16(1):7338. doi: 10.1038/s41467-025-62500-8.

本文引用的文献

1
High-precision mapping reveals the structure of odor coding in the human brain.高精度图谱揭示人类大脑嗅觉编码结构。
Nat Neurosci. 2023 Sep;26(9):1595-1602. doi: 10.1038/s41593-023-01414-4. Epub 2023 Aug 24.
2
Properties of odor identification testing in screening for early-stage Alzheimer's disease.嗅觉识别测试在早期阿尔茨海默病筛查中的特性。
Sci Rep. 2023 Apr 13;13(1):6075. doi: 10.1038/s41598-023-32878-w.
3
2023 Alzheimer's disease facts and figures.2023 年阿尔茨海默病事实和数据。
Alzheimers Dement. 2023 Apr;19(4):1598-1695. doi: 10.1002/alz.13016. Epub 2023 Mar 14.
4
Different z-score cut-offs for striatal binding ratio (SBR) of DaT SPECT are needed to support the diagnosis of Parkinson's Disease (PD) and dementia with Lewy bodies (DLB).需要不同的纹状体结合比(SBR)DaT SPECT 的 Z 分数截断值来支持帕金森病(PD)和路易体痴呆(DLB)的诊断。
Eur J Nucl Med Mol Imaging. 2023 Mar;50(4):1090-1102. doi: 10.1007/s00259-022-06069-0. Epub 2022 Dec 6.
5
Olfactory Bulb Amyloid-β Correlates With Brain Thal Amyloid Phase and Severity of Cognitive Impairment.嗅球淀粉样蛋白-β与脑内淀粉样相及认知障碍严重程度相关。
J Neuropathol Exp Neurol. 2022 Jul 19;81(8):643-649. doi: 10.1093/jnen/nlac042.
6
The human connectome in Alzheimer disease - relationship to biomarkers and genetics.阿尔茨海默病的人类连接组学——与生物标志物和遗传学的关系。
Nat Rev Neurol. 2021 Sep;17(9):545-563. doi: 10.1038/s41582-021-00529-1. Epub 2021 Jul 20.
7
Olfaction as an early marker of Parkinson's disease and Alzheimer's disease.嗅觉障碍作为帕金森病和阿尔茨海默病的早期标志物。
Handb Clin Neurol. 2021;182:317-329. doi: 10.1016/B978-0-12-819973-2.00030-7.
8
Developing the ATX(N) classification for use across the Alzheimer disease continuum.制定用于整个阿尔茨海默病连续体的 ATX(N) 分类。
Nat Rev Neurol. 2021 Sep;17(9):580-589. doi: 10.1038/s41582-021-00520-w. Epub 2021 Jul 8.
9
Biomarkers for neurodegenerative diseases.神经退行性疾病的生物标志物。
Nat Med. 2021 Jun;27(6):954-963. doi: 10.1038/s41591-021-01382-x. Epub 2021 Jun 3.
10
The Alzheimer's Association international guidelines for handling of cerebrospinal fluid for routine clinical measurements of amyloid β and tau.阿尔茨海默病协会国际指南:用于常规临床测量淀粉样β和tau 的脑脊液处理。
Alzheimers Dement. 2021 Sep;17(9):1575-1582. doi: 10.1002/alz.12316. Epub 2021 Mar 31.